Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPEP | Q07075 | 5/20 | 0.51 |
| ▸ | BACE1 | P56817 | 12/20 | 0.49 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.45 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.44 |
| ▸ | CTSD | P07339 | 1/20 | 0.43 |
| ▸ | MDM4 | O15151 | 1/20 | 0.43 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30163434 | 0.92 | BACE1 (0.52) | ENPEPBACE1FOLH1BACE2MDM4 | |
| SCHEMBL29931628 | 0.91 | ENPEP (0.53) | ENPEPBACE1 | |
| SCHEMBL29931588 | 0.91 | ENPEP (0.53) | ENPEPBACE1 | |
| SCHEMBL29391346 | 0.91 | CTSD (0.44) | ENPEPBACE1FOLH1CTSD | |
| SCHEMBL31432463 | 0.90 | FOLH1 (0.48) | ENPEPFOLH1 | |
| SCHEMBL29539536 | 0.90 | FOLH1 (0.48) | ENPEPFOLH1 | |
| SCHEMBL30053260 | 0.88 | FOLH1 (0.42) | ENPEPBACE1FOLH1CTSD | |
| SCHEMBL24725397 | 0.87 | BACE1 (0.52) | ENPEPBACE1BACE2CTSDMDM4 | |
| SCHEMBL30051366 | 0.87 | ENPEP (0.49) | ENPEP | |
| SCHEMBL29709563 | 0.86 | FOLH1 (0.44) | ENPEPBACE1FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240319146-A1 | ANALYSIS METHOD FOR PEPTIDE BOUND TO CARRIER FOR LIQUID PHASE PEPTIDE SYNTHESIS | PEPTISTAR INC. (JP) | 2024-09-26 | — | — | US | disclosed |
| EP-4365184-A1 | ANALYSIS METHOD FOR PEPTIDE BOUND TO CARRIER FOR LIQUID PHASE PEPTIDE SYNTHESIS | Peptistar Inc. (JP) | 2024-05-08 | — | — | EP | disclosed |
| WO-2023277186-A1 | ANALYSIS METHOD FOR PEPTIDE BOUND TO CARRIER FOR LIQUID PHASE PEPTIDE SYNTHESIS | ペプチスター株式会社 | 2023-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240319146-A1 | ANALYSIS METHOD FOR PEPTIDE BOUND TO CARRIER FOR LIQUID PHASE PEPTIDE SYNTHESIS | HDGF, VIP, NPPA | ENPEP 23/4885BACE1 3899/4885FOLH1 210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.